News
1d
The Print on MSNIndia sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arenaIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.
The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, ...
Curious about the viral “Japanese Mounjaro” drink? Learn what it is, what it’s made of, and whether it can actually support weight loss like the prescription medication Mounjaro.
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results